MY ACCOUNT | NEWSLETTER |

Tartar Shield® Natural Pet Toothpaste Granted VOHC® Seal of Acceptance


The Veterinary Oral Health Council (VOHC®) has awarded the VOHC Seal of Acceptance to Tartar Shield® Pro Care Natural Pet Toothpaste for tartar control in dogs.

On the VOHC’s recommendation, ratified by the American Veterinary Dental College (AVDC) Board of Directors, the recognition affirms the product’s clinically demonstrated ability to reduce tartar accumulation and highlights its role in advancing preventive oral health standards in veterinary practice.

Clinical studies conducted under VOHC protocols, using only topical application with no brushing device required, demonstrated that Tartar Shield® Pro Care Natural Pet Toothpaste significantly reduced tartar, plaque, and halitosis. These findings reflect Tartar Shield’s longstanding commitment to science-driven performance and its continued efforts to elevate the quality and effectiveness of pet oral care.

Tartar Shield® Pro Care is a coconut oil–based toothpaste formulated with all-natural and nature-derived ingredients. It is the first and only chemically active pet toothpaste awarded VOHC’s prestigious Seal of Acceptance — the foremost standard recognized globally across veterinary and consumer pet dental product categories.

“Tartar Shield® has demonstrated a strong commitment to scientific rigor and to supporting the VOHC’s mission to provide assurance of clinical efficacy for pet oral care,” said Ellen Lowery, DVM, PhD, Director of the VOHC.

About Tartar Shield Pet Products, Inc.

Tartar Shield® develops science-driven oral care solutions for pets. Building on the research legacy of Dr. George K. Stookey, the pioneering dental scientist whose work helped establish modern standards in both human and veterinary dentistry, the company champions preventive health through clinically proven formulations that support better oral hygiene and long-term wellness. Tartar Shield® is headquartered in Noblesville, Indiana.


Source: www.tartarshield.com

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

40 Under 40: Dr. Cassi Fleming

Like0
Dislike0

CORRECTING and REPLACING Petwealth Emerges from Stealth with $1.7 Million in Funding, Landmark Partnerships, and a Mission to Become the Functional Health Platform for Pets

Like0
Dislike0

Unlocking the potential of ICT innovation in veterinary healthcare: The pathway to improve practices and business model

Like0
Dislike0

Canine papillomavirus: status of diagnostic methods and vaccine innovations

Like0
Dislike0

Analysing innovations among cattle smallholders to evaluate the adequacy of breeding programs

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top